Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

High-cholesterol diet in combination with hydroxypropyl-beta-cyclodextrin induces NASH-like disorders in the liver of rats

Y. Saigo, T. Sasase, M. Tohma, K. Uno, Y. Shinozaki, T. Maekawa, R. Sano, K. Miyajima, T. Ohta

. 2023 ; 72 (3) : 371-382. [pub] 2023Jul14

Language English Country Czech Republic

Document type Journal Article

Non-alcoholic fatty liver disease (NAFLD) is a general term for fatty liver disease not caused by viruses or alcohol. Fibrotic hepatitis, cirrhosis, and hepatocellular carcinoma can develop. The recent increase in NAFLD incidence worldwide has stimulated drug development efforts. However, there is still no approved treatment. This may be due in part to the fact that non-alcoholic steatohepatitis (NASH) pathogenesis is very complex, and its mechanisms are not well understood. Studies with animals are very important for understanding the pathogenesis. Due to the close association between the establishment of human NASH pathology and metabolic syndrome, several animal models have been reported, especially in the context of overnutrition. In this study, we investigated the induction of NASH-like pathology by enhancing cholesterol absorption through treatment with hydroxypropyl-beta-cyclodextrin (CDX). Female Sprague-Dawley rats were fed a normal diet with normal water (control group); a high-fat (60 kcal%), cholesterol (1.25 %), and cholic acid (0.5 %) diet with normal water (HFCC group); or HFCC diet with 2 % CDX water (HFCC+CDX group) for 16 weeks. Compared to the control group, the HFCC and HFCC+CDX groups showed increased blood levels of total cholesterol, aspartate aminotransferase, and alanine aminotransferase. At autopsy, parameters related to hepatic lipid synthesis, oxidative stress, inflammation, and fibrosis were elevated, suggesting the development of NAFLD/NASH. Elevated levels of endoplasmic reticulum stress-related genes were evident in the HFCC+CDX group. In the novel rat model, excessive cholesterol intake and accelerated absorption contributed to NAFLD/NASH pathogenesis.

000      
00000naa a2200000 a 4500
001      
bmc23012415
003      
CZ-PrNML
005      
20230823152048.0
007      
ta
008      
230804s2023 xr da f 000 0|eng||
009      
AR
024    7_
$2 doi $a 10.33549/physiolres.934981
035    __
$a (PubMed)37449749
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Saigo, Yasuka $u Biological/Pharmacological Research Laboratories, Takatsuki Research Center, Central Pharmaceutical Research Institute, Japan Tobacco Inc., Osaka, Japan $u Laboratory of Animal Physiology and Functional Anatomy, Graduate School of Agriculture, Kyoto University, Kyoto, Japan
245    10
$a High-cholesterol diet in combination with hydroxypropyl-beta-cyclodextrin induces NASH-like disorders in the liver of rats / $c Y. Saigo, T. Sasase, M. Tohma, K. Uno, Y. Shinozaki, T. Maekawa, R. Sano, K. Miyajima, T. Ohta
520    9_
$a Non-alcoholic fatty liver disease (NAFLD) is a general term for fatty liver disease not caused by viruses or alcohol. Fibrotic hepatitis, cirrhosis, and hepatocellular carcinoma can develop. The recent increase in NAFLD incidence worldwide has stimulated drug development efforts. However, there is still no approved treatment. This may be due in part to the fact that non-alcoholic steatohepatitis (NASH) pathogenesis is very complex, and its mechanisms are not well understood. Studies with animals are very important for understanding the pathogenesis. Due to the close association between the establishment of human NASH pathology and metabolic syndrome, several animal models have been reported, especially in the context of overnutrition. In this study, we investigated the induction of NASH-like pathology by enhancing cholesterol absorption through treatment with hydroxypropyl-beta-cyclodextrin (CDX). Female Sprague-Dawley rats were fed a normal diet with normal water (control group); a high-fat (60 kcal%), cholesterol (1.25 %), and cholic acid (0.5 %) diet with normal water (HFCC group); or HFCC diet with 2 % CDX water (HFCC+CDX group) for 16 weeks. Compared to the control group, the HFCC and HFCC+CDX groups showed increased blood levels of total cholesterol, aspartate aminotransferase, and alanine aminotransferase. At autopsy, parameters related to hepatic lipid synthesis, oxidative stress, inflammation, and fibrosis were elevated, suggesting the development of NAFLD/NASH. Elevated levels of endoplasmic reticulum stress-related genes were evident in the HFCC+CDX group. In the novel rat model, excessive cholesterol intake and accelerated absorption contributed to NAFLD/NASH pathogenesis.
650    _2
$a lidé $7 D006801
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a zvířata $7 D000818
650    12
$a nealkoholová steatóza jater $x chemicky indukované $7 D065626
650    _2
$a hydroxypropyl beta cyklodextrin $x metabolismus $x terapeutické užití $7 D000073738
650    _2
$a potkani Sprague-Dawley $7 D017207
650    _2
$a dieta s vysokým obsahem tuků $x škodlivé účinky $7 D059305
650    _2
$a játra $x metabolismus $7 D008099
650    _2
$a cholesterol $7 D002784
650    12
$a hypercholesterolemie $x metabolismus $7 D006937
650    12
$a hyperlipidemie $7 D006949
650    _2
$a modely nemocí na zvířatech $7 D004195
655    _2
$a časopisecké články $7 D016428
700    1_
$a Sasase, Tomohiko $u Biological/Pharmacological Research Laboratories, Takatsuki Research Center, Central Pharmaceutical Research Institute, Japan Tobacco Inc., Osaka, Japan $u Laboratory of Animal Physiology and Functional Anatomy, Graduate School of Agriculture, Kyoto University, Kyoto, Japan
700    1_
$a Tohma, Marika $u Department of Nutritional Science and Food Safety, Faculty of Applied Biosciences, Tokyo University of Agriculture, Tokyo, Japan
700    1_
$a Uno, Kinuko $u Department of Nutritional Science and Food Safety, Faculty of Applied Biosciences, Tokyo University of Agriculture, Tokyo, Japan
700    1_
$a Shinozaki, Yuichi $u Biological/Pharmacological Research Laboratories, Takatsuki Research Center, Central Pharmaceutical Research Institute, Japan Tobacco Inc., Osaka, Japan $u Laboratory of Animal Physiology and Functional Anatomy, Graduate School of Agriculture, Kyoto University, Kyoto, Japan
700    1_
$a Maekawa, Tatsuya $u Biological/Pharmacological Research Laboratories, Takatsuki Research Center, Central Pharmaceutical Research Institute, Japan Tobacco Inc., Osaka, Japan
700    1_
$a Sano, Ryuhei $u Biological/Pharmacological Research Laboratories, Takatsuki Research Center, Central Pharmaceutical Research Institute, Japan Tobacco Inc., Osaka, Japan $u Department of Nutritional Science and Food Safety, Faculty of Applied Biosciences, Tokyo University of Agriculture, Tokyo, Japa
700    1_
$a Miyajima, Katsuhiro $u Department of Nutritional Science and Food Safety, Faculty of Applied Biosciences, Tokyo University of Agriculture, Tokyo, Japan
700    1_
$a Ohta, Takeshi $u Laboratory of Animal Physiology and Functional Anatomy, Graduate School of Agriculture, Kyoto University, Kyoto, Japan
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 72, č. 3 (2023), s. 371-382
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37449749 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20230804 $b ABA008
991    __
$a 20230823152046 $b ABA008
999    __
$a ok $b bmc $g 1972834 $s 1198684
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 72 $c 3 $d 371-382 $e 2023Jul14 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK198 $a Pubmed-20230804

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...